Business
Canatu grants license for commercial production of CNT pellicle membranes using CNT100 SEMI reactor
Canatu CNT pellicle membrane Canatu CNT SEMI 100 reactors are used for CNT pellicle membrane production VANTAA, Finland, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Canatu has granted a commercial production license for the first CNT100 SEMI reactor to Korean semiconductor company FINE SEMITECH CORPORATION (hereinafter “FST”). The license authorizes FST as the licensee to mass-produce CNT pellicle membranes using the CNT100 SEMI reactor, which will be operated by FST. FST will pay Canatu a one-time licens
About this update from Canatu Plc
[{"type":"image","alt":"Canatu","displaySize":"","headline":null,"caption":"Canatu","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":137,"url":"https://media.zenfs.com/en/globenewswire.com/7d04ecc83bb95c7ee910787b5b3420d1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Uz.sBY3VgKrbYI4V7K5U0A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE5MjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/7d04ecc83bb95c7ee910787b5b3420d1","width":300,"height":137}},"lazy":false},{"type":"text","content":"Canatu CNT pellicle membrane","length":28,"tagName":"p"},{"type":"image","alt":"Canatu CNT SEMI 100 reactors are used for CNT pellicle membrane production","displaySize":"","headline":null,"caption":"Canatu CNT SEMI 100 reactors are used for CNT pellicle membrane production","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":4032,"height":3024,"url":"https://media.zenfs.com/en/globenewswire.com/794df548d6face42ebf305a42626a96d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/A3jnW5bmJyaMo0qbvWHmGA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTcyMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/794df548d6face42ebf305a42626a96d","width":960,"height":720},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/WQ_PsViJ1fjrXN_D1A671Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xODAwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/794df548d6face42ebf305a42626a96d","width":1200,"height":900}}},{"type":"text","content":"VANTAA, Finland, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Canatu has granted a commercial production license for the first CNT100 SEMI reactor to Korean semiconductor company FINE SEMITECH CORPORATION (hereinafter “FST”). The license authorizes FST as the licensee to mass-produce CNT pellicle membranes using the CNT100 SEMI reactor, which will be operated by FST. FST will pay Canatu a one-time license fee for the commercial production rights.","length":439,"tagName":"p"},{"type":"text","content":"The value of the one-time license fee for commercial production of CNT pellicle membranes is classified within the lower half of the “Medium” (1.0- 5.0M€) category under Canatu’s disclosure policy. The related revenue will be recognized in Q4/2025.","length":248,"tagName":"p"},{"type":"text","content":"The commencement of commercial production will also create two new sources of future rev...